Thu, Oct 23, 2014, 5:50 AM EDT - U.S. Markets open in 3 hrs 40 mins

Recent

% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

  • brnicegy brnicegy Jun 16, 2013 9:18 AM Flag

    Looking for comparable situations...

    Does anyone else know of an FDA approved drug which had "problems", but was fixed and later rebounded? If you do, it would help the ones on the fence to know its at least a possibility. Not that past performance is a guarantee of future rise in PPS, but it would help the case for the longs to see a scenario that has happened before. Thanks.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Even what some regard as the most harmful drug ever (THALIDOMIDE), which was completely withdrawn, ultimately returned to the market and is NOW being used for several different conditions. Of the approximately 2,000 babies born with the most horribly disfiguring defects, around half died within a few months and 466 survived to at least 2010

      Google Thalidomide and read in particular the wikipedia synopsis of what happened and its current status as an ACTIVE DRUG on the market...

      • 1 Reply to maxdad01
      • Maxdad, you are providing misleading info regarding thalidomide. First, the estimated number of birth defects due to thalidomide numbers from 5,000 to 10,000, not the 2000 number you mention. Second, you fail to mention that thalidomide NEVER returned for what it was marketed for...treatment of morning sickness. It was later to have found useful in things like leprosy and cachexia. Any comparison of thalidomide to O is a stretch to say the least.

        Sentiment: Strong Sell

    • Elan Tysabri recall in 2005. I didn't participate it out of fear, and still regret it all this time.

 
AFFY
0.120.00(0.00%)Oct 22 1:51 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.